Shanghai Mental Health Center, Shanghai Jiao Tong, University School of Medicine, 600 Wanping Nan Road, Shanghai, Prc, 200030, China.
Shanghai Key Laboratory of Psychotic Disorders; CAS Center for Excellence in Brain Science and Intelligence Technology (CEBSIT), Chinese Academy of Sciences, 319 Yueyang Road, Shanghai, Prc, 200031, China.
Alcohol Alcohol. 2022 Nov 11;57(6):742-748. doi: 10.1093/alcalc/agac030.
The present study was a randomized controlled trial with a longitudinal design aimed at examining the effectiveness of Screening, Brief Intervention and Referral to Treatment (SBIRT) on harmful alcohol use in the community health centres in Shanghai, China, and further compared the effects of a multi-session brief intervention (MBI) and a single-session brief intervention (SBI).
A total of 362 participants were recruited from four districts of Shanghai and randomly assigned to MBI, SBI and routine care (RC) groups. The MBI group received the brief intervention twice. Follow-up assessments were conducted at 1 and 3 months after the intervention.
Compared with the SBI and the RC groups, the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) scores (F = 6.422, P = 0.002), SDS scores (F = 5.779, P = 0.003) and SAS scores (F = 4.004, P = 0.019) were significant improved in the MBI group at 1and 3-month follow-up assessment. In the SBI group, the SDS scores decreased significantly compared with the RC group, and there were no significant differences in ASSIST scores, drinking knowledge scores and SAS scores 1-month follow-up assessment.
The findings suggested that SBIRT with two sessions of BI had considerable effects on individuals with harmful alcohol use. It provided clinical evidence for future use in China and other Asian countries with similar situations.
本研究采用随机对照纵向设计，旨在检验中国上海社区卫生中心基于 Screening、Brief Intervention and Referral to Treatment（SBIRT）的有害饮酒干预措施的有效性，并进一步比较多疗程简短干预（MBI）和单疗程简短干预（SBI）的效果。
共招募了 362 名来自上海四个区的参与者，随机分为 MBI、SBI 和常规护理（RC）组。MBI 组接受两次简短干预。干预后 1 个月和 3 个月进行随访评估。
与 SBI 和 RC 组相比，MBI 组在干预后 1 个月和 3 个月的酒精、吸烟和物质使用情况筛查测试（ASSIST）评分（F=6.422，P=0.002）、抑郁自评量表（SDS）评分（F=5.779，P=0.003）和焦虑自评量表（SAS）评分（F=4.004，P=0.019）均显著改善。在 SBI 组中，与 RC 组相比，SDS 评分显著下降，而 ASSIST 评分、饮酒知识评分和 SAS 评分在干预后 1 个月时无显著差异。
这些发现表明，两次 BI 的 SBIRT 对有害饮酒者具有显著效果。它为未来在中国和其他类似情况的亚洲国家的应用提供了临床依据。
